Ask for more info

Country Afghanistan Africa Albania Algeria Andorra Angola Antigua and Barbuda Argentina Armenia Asia Australia Austria Austria Azerbaijan Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burm (Myanmar) Burundi Cambodia Cameroon Canada Cape Verde Central African Republic Chad Chile China Colombia Congo Congo, Democratic Republic Costa Rica Croatia Cte d’Ivoire Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Europe European Union Fiji Finland France Gabon Georgia Germany Ghana Greece Grenada Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hong Cong - China Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Maccedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Micronesia Middle East Moldova Monaco Mongolia Morocco Mozambique Namibia Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Qatar Romania Russia Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia and Montenegro Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Srilanka Sudan Suriname Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand The Bahamas The Comoros The Gambia Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Unrestricted Unspecified Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Yemen Yugoslavia Zambia Zimbabwe Message Please enter the numbers

GlaxoSmithKline (GSK) - Case Study

Fleet Management System

ICT Department

East Africa Portland Cement Co. Ltd

P.O.Box 20-00204

Nairobi

Dear Sir,

Ref: Africa Fleet Management Solutions

We gave been using your fleet management system for the last two years. We started with a pilot project of 22 vehicles and we have seen a tremendous change in the overall performance of our drivers. There has been a drastic reduction in the number of accidents, which means our down time is greatly reduced.

We have been able to keep track of our sales force and the vehicle performance at all given times resulting into cutting down on running costs and increased efficiency.

We are quite satisfied with your services and we would not hesitate to provide references.

Yours faithfully,

GlaxoSmithKline

(Signed)

Sales Force Effectiveness Manager, East Africa